{
    "code": "52026217",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026217",
    "time": "2016-09-30 03:07:16",
    "許可證字號": "衛部藥輸字第026217號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/03\/18",
    "發證日期": "103\/03\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202621701",
    "中文品名": "貝坦利持續性藥效錠25毫克",
    "英文品名": "Betmiga Prolonged-release Tablets 25mg",
    "適應症": "治療伴有急尿、頻尿和\/或急迫性尿失禁症狀的膀胱過動症",
    "劑型": "121持續性藥效錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "Mirabegron",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "620110R660  台灣安斯泰來製藥股份有限公司",
    "申請商地址": "台北市中山區民生東路３段１０號５樓",
    "主製造廠": {
        "製造廠名稱": "F460472000  ASTELLAS PHARMA TECHNOLOGIES, INC.",
        "製造廠廠址": "3300 MARSHALL AVE. NORMAN, OK 73072 USA",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED STATES",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F170047000  ASTELLAS PHARMA EUROPE B.V.",
            "製造廠廠址": "HOGEMAAT 2, 7942 JG MEPPEL, THE NETHERLANDS",
            "製造廠公司地址": "SYLVIUSWEG 62, 2333 BE LEIDEN, THE NETHERLANDS.",
            "製造廠國別": "NETHERLANDS",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "F269414000  ASTELLAS PHARMA TECH CO., LTD. TAKAHAGI TECHNOLOGY CENTER",
            "製造廠廠址": "160-2, AKAHARNA, TAKAHAGI-SHI, IBARAKI 318-0001, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200080700",
            "成分名稱": "Mirabegron",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Betmiga Chinese PI (revised 20160419)-105-08-01.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=005&Type=9"
        },
        {
            "title": "貝坦利仿單 (BET-I150903)-104-12-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=003&Type=9"
        },
        {
            "title": "貝坦利持續性藥效錠仿單-104-10-13(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=004&Type=9"
        },
        {
            "title": "貝坦利持續性藥效錠25, 50毫克仿單(2,3,4頁)-2014-08-29.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=002&Type=9"
        },
        {
            "title": "貝坦利持續性藥效錠25, 50毫克仿單(1,6,5,頁)-2014-08-29.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=001&Type=9"
        },
        {
            "title": "貝坦利持續性藥效錠25mg正反面外盒-104-10-13(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=005&Type=8"
        },
        {
            "title": "貝坦利持續性藥效錠25mg外盒-104-10-13(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=004&Type=8"
        },
        {
            "title": "026217-2014-08-29.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=003&Type=8"
        },
        {
            "title": "貝坦利25毫克鋁箔-103-04-28.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=002&Type=8"
        },
        {
            "title": "貝坦利25毫克外盒-103-04-28.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026217&Seq=001&Type=8"
        }
    ]
}